Illumina Announces Mitsubishi Chemical Safety Institute as Japan's First Certified Genetic Analysis Service Provider
News Jun 20, 2008
Illumina, Inc. has announced that Mitsubishi Chemical Safety Institute, a provider of various analyses, examinations, and services for pharmaceutical companies, public institutions, and chemical companies, is the first organization in Japan to become an Illumina CSPro® (certified service provider).
Illumina CSPro is a collaborative service provider partnership dedicated to ensuring the delivery of the highest-quality data available for genetic analysis applications.
Mitsubishi Chemical Safety Institute offers its customers whole-genome and targeted-genotyping services using Illumina's Infinium® and GoldenGate® Assays. Both assays leverage Illumina's proprietary BeadArray® technology to provide customers the ability to perform large-scale interrogation of the human genome, which enables them to fast forward their research and identify genetic variants linked to disease.
"For the last seven years, we have concentrated on the investigation of toxicogenomics and pharmacogenomics, and have consequently acquired an abundance of experience in the development of genomic analysis technologies," said Masaru Sekijima, Ph.D., General Manager of Advanced Medical Science Research Center, Mitsubishi Chemical Safety Institute.
"As a result of this hard work, we are excited to become the first Illumina CSPro in Japan, making it possible to provide researchers with the level of high-quality genomic data customers have come to expect from Illumina."
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019